×

ENTER REPORT NAME TO SEARCH

Global Neonatal Respiratory Distress Syndrome Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report ID: GIR2302130031 | Category: Service & Software | Pages: 104 | Format: PDF | Published Date: February 27,2023


Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Neonatal Respiratory Distress Syndrome Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Neonatal Respiratory Distress Syndrome Treatment by Type
        1.3.1 Overview: Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Neonatal Respiratory Distress Syndrome Treatment Consumption Value Market Share by Type in 2022
        1.3.3 Oxygen Therapy
        1.3.4 Surfactant Therapy
        1.3.5 Others
    1.4 Global Neonatal Respiratory Distress Syndrome Treatment Market by Application
        1.4.1 Overview: Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Home Care
        1.4.4 Others
    1.5 Global Neonatal Respiratory Distress Syndrome Treatment Market Size & Forecast
    1.6 Global Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast by Region
        1.6.1 Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Size by Region, (2018-2029)
        1.6.3 North America Neonatal Respiratory Distress Syndrome Treatment Market Size and Prospect (2018-2029)
        1.6.4 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Size and Prospect (2018-2029)
        1.6.6 South America Neonatal Respiratory Distress Syndrome Treatment Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Neonatal Respiratory Distress Syndrome Treatment Market Size and Prospect (2018-2029)
2 Company Profiles
    2.1 Medtronic
        2.1.1 Medtronic Details
        2.1.2 Medtronic Major Business
        2.1.3 Medtronic Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.1.4 Medtronic Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Medtronic Recent Developments and Future Plans
    2.2 Dragerwerk
        2.2.1 Dragerwerk Details
        2.2.2 Dragerwerk Major Business
        2.2.3 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.2.4 Dragerwerk Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Dragerwerk Recent Developments and Future Plans
    2.3 GE HealthCare
        2.3.1 GE HealthCare Details
        2.3.2 GE HealthCare Major Business
        2.3.3 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.3.4 GE HealthCare Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 GE HealthCare Recent Developments and Future Plans
    2.4 Koninklijke Philips
        2.4.1 Koninklijke Philips Details
        2.4.2 Koninklijke Philips Major Business
        2.4.3 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.4.4 Koninklijke Philips Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Koninklijke Philips Recent Developments and Future Plans
    2.5 Smiths Medical
        2.5.1 Smiths Medical Details
        2.5.2 Smiths Medical Major Business
        2.5.3 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.5.4 Smiths Medical Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Smiths Medical Recent Developments and Future Plans
    2.6 Fisher & Paykel Healthcare
        2.6.1 Fisher & Paykel Healthcare Details
        2.6.2 Fisher & Paykel Healthcare Major Business
        2.6.3 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.6.4 Fisher & Paykel Healthcare Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Fisher & Paykel Healthcare Recent Developments and Future Plans
    2.7 IBIO
        2.7.1 IBIO Details
        2.7.2 IBIO Major Business
        2.7.3 IBIO Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.7.4 IBIO Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 IBIO Recent Developments and Future Plans
    2.8 Windtree Therapeutics
        2.8.1 Windtree Therapeutics Details
        2.8.2 Windtree Therapeutics Major Business
        2.8.3 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.8.4 Windtree Therapeutics Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Windtree Therapeutics Recent Developments and Future Plans
    2.9 Synthetic Biologics
        2.9.1 Synthetic Biologics Details
        2.9.2 Synthetic Biologics Major Business
        2.9.3 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.9.4 Synthetic Biologics Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Synthetic Biologics Recent Developments and Future Plans
    2.10 Synairgen 
        2.10.1 Synairgen Details
        2.10.2 Synairgen Major Business
        2.10.3 Synairgen Neonatal Respiratory Distress Syndrome Treatment Product and Solutions
        2.10.4 Synairgen Neonatal Respiratory Distress Syndrome Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Synairgen Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Neonatal Respiratory Distress Syndrome Treatment Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Neonatal Respiratory Distress Syndrome Treatment by Company Revenue
        3.2.2 Top 3 Neonatal Respiratory Distress Syndrome Treatment Players Market Share in 2022
        3.2.3 Top 6 Neonatal Respiratory Distress Syndrome Treatment Players Market Share in 2022
    3.3 Neonatal Respiratory Distress Syndrome Treatment Market: Overall Company Footprint Analysis
        3.3.1 Neonatal Respiratory Distress Syndrome Treatment Market: Region Footprint
        3.3.2 Neonatal Respiratory Distress Syndrome Treatment Market: Company Product Type Footprint
        3.3.3 Neonatal Respiratory Distress Syndrome Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Neonatal Respiratory Distress Syndrome Treatment Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
    5.1 Global Neonatal Respiratory Distress Syndrome Treatment Consumption Value Market Share by Application (2018-2023)
    5.2 Global Neonatal Respiratory Distress Syndrome Treatment Market Forecast by Application (2024-2029)
6 North America
    6.1 North America Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Type (2018-2029)
    6.2 North America Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Application (2018-2029)
    6.3 North America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country
        6.3.1 North America Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Country (2018-2029)
        6.3.2 United States Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        6.3.3 Canada Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        6.3.4 Mexico Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
7 Europe
    7.1 Europe Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Type (2018-2029)
    7.2 Europe Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Application (2018-2029)
    7.3 Europe Neonatal Respiratory Distress Syndrome Treatment Market Size by Country
        7.3.1 Europe Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Country (2018-2029)
        7.3.2 Germany Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        7.3.3 France Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        7.3.5 Russia Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        7.3.6 Italy Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
8 Asia-Pacific
    8.1 Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Market Size by Region
        8.3.1 Asia-Pacific Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Region (2018-2029)
        8.3.2 China Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        8.3.3 Japan Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        8.3.4 South Korea Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        8.3.5 India Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        8.3.7 Australia Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
9 South America
    9.1 South America Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Type (2018-2029)
    9.2 South America Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Application (2018-2029)
    9.3 South America Neonatal Respiratory Distress Syndrome Treatment Market Size by Country
        9.3.1 South America Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Country (2018-2029)
        9.3.2 Brazil Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        9.3.3 Argentina Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
10 Middle East & Africa
    10.1 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Market Size by Country
        10.3.1 Middle East & Africa Neonatal Respiratory Distress Syndrome Treatment Consumption Value by Country (2018-2029)
        10.3.2 Turkey Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
        10.3.4 UAE Neonatal Respiratory Distress Syndrome Treatment Market Size and Forecast (2018-2029)
11 Market Dynamics
    11.1 Neonatal Respiratory Distress Syndrome Treatment Market Drivers
    11.2 Neonatal Respiratory Distress Syndrome Treatment Market Restraints
    11.3 Neonatal Respiratory Distress Syndrome Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
    12.1 Neonatal Respiratory Distress Syndrome Treatment Industry Chain
    12.2 Neonatal Respiratory Distress Syndrome Treatment Upstream Analysis
    12.3 Neonatal Respiratory Distress Syndrome Treatment Midstream Analysis
    12.4 Neonatal Respiratory Distress Syndrome Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

It contains all the geographic trends, and market analysis for global market